Risk Factors for Valvulopathy Among Childhood Cancer Survivors Rivalin Aho Glele, Elizabeth A. M. Feijen, Brice Fresneau, Raoul C. Reulen, Rodrigue S. Allodji, Giao Vu-Bezin, Boris Schwartz, Neige Journy, Véronique Minard-Colin, Francesca Bagnasco, Edit Bardi, Fabiën N. Belle, Julianne Byrne, Elvira C. van Dalen, Jop C. Teepen, Desiree Grabow, Peter Kaatsch, Lars Hjorth, Momcilo Jankovic, Claudia E. Kuehni, Gillian Levitt, Cristina Veres, Isabelle Aerts, Lorna Zadravec Zaletel, Helena J. H. van der Pal, Cecile Ronckers, Carlotta Sacerdote, Roderick Skinner, Zsuzsanna Jakab, Gisela Michel, Monica Terenziani, Nadia Haddy, Isabelle Thierry-Chef, Elisabeth Cardis, Ibrahima Diallo, David L. Winter, Leontien C. M. Kremer, Mike M. Hawkins, Florent de Vathaire JAMA Oncology, 2025 ImportanceSubstantial improvements in childhood cancer survival have created a critical need to address serious long-term health complications, such as valvular heart disease (VHD).ObjectiveTo identify treatment-related risk factors for VHD in a large European cohort of long-term childhood cancer survivors.Design, Setting, and ParticipantsThis nested case-control study used data from the PanCareSurFup (PanCare Childhood and Adolescent Cancer Survivor Care and Follow-Up Studies) and ProCardio cohorts, including detailed radiation dose reconstruction and chemotherapy exposure, for childhood cancer survivors from 7 European countries, diagnosed between 1940 and 2009, who survived at least 5 years after cancer diagnosis. Case patients, defined as having symptomatic VHD, were matched with controls 1:2 by subcohort, sex, age at cancer diagnosis, and calendar year of initial diagnosis. Data were analyzed from October 2023 to June 2025.ExposuresDoses were calculated by performing a whole-body dosimetric reconstruction using a voxel-based anthropomorphic phantom with more than 200 delineated anatomic structures or substructures. Cumulative dose to cytotoxic agents was also assessed.Main Outcome and MeasureDevelopment of symptomatic VHD (grade ≥3 per the Common Terminology and Criteria for Adverse Events, version 4.03).ResultsOf the 225 cases, 136 participants (60.4%) were male, and 195 (86.7%) were diagnosed with VHD beyond 20 years from childhood cancer. Survivors receiving a mean heart radiation therapy (RT) dose of 5 to less than 15 Gy had an increased risk of VHD (odds ratio [OR], 4.7; 95% CI, 2.1-10.7) compared to those without heart RT, with higher risk when more than half of the heart was exposed. The heart RT dose response appeared exponential, with the OR being 104.1 (95% CI, 27.8-389.6) for mean heart dose of 30 Gy or more, increasing considerably with follow-up from 6.0 (95% CI, 1.4-26.5) after 5 to 19 years to 71.4 (95% CI, 20.4-250.0) after 30 or more years. Cumulative anthracycline doses of 400 mg/m2 or higher were also associated with increased VHD risk (OR, 3.8; 95% CI, 1.4-10.3), showing an exponential dose-response pattern. Cumulative exposure to platinum agents was associated with VHD risk in a linear manner. No statistically significant associations were found for other chemotherapy agents or radiation to the spleen.Conclusion and RelevanceIn this case-control study, heart RT, anthracyclines, and platinum agents were associated with increased VHD risk in childhood cancer survivors. Risks from both RT and anthracyclines were amplified with age and follow-up, underscoring the need for long-term cardiac surveillance.
Vaginal germ cell tumors: results from the international retrospective VAGIPED study Cécile Faure-Conter, Luiz Fernando Lopes, Yijin Gao, Gabriele Calaminus, Monica Terenziani, Maria Debora De Pasquale, Agnes Vojcek, Orjana Velikonja, Joanna Stefanowicz, Shayi Jiang, Xiaojun Yuan, Yali Han, Ricardo López-Almaraz, Anthony Penn, Claire Stokes, Michelle Nuno, Lindsay Frazier, Deborah F. Billmire, Brice Fresneau, Claire Cropet British Journal of Cancer, 2025
Risk factors for relapse and guidance for follow-up of extracranial immature teratomas in children: A systematic review Dana G.M. Peters, Caroline C.C. Hulsker, Leendert H.J. Looijenga, Ronald R. de Krijger, Annemieke S. Littooij, Jeanette van Leeuwen, Aart J. Klijn, Monica Terenziani, Cecile Faure-Conter, Gabriele Calaminus, Annelies M.C. Mavinkurve-Groothuis Ejc Paediatric Oncology, 2025 <h2>Abstract</h2><h3>Objective</h3> This systematic review was performed to identify risk factors for recurrence of extracranial immature teratomas (ITs) and to provide recommendations for post-operative follow-up. <h3>Methods</h3> The search focused on risk factors for recurrent disease and/or follow-up management of extracranial IT in the paediatric population. The initial search, conducted across three databases, yielded 2131 articles. Ultimately six articles were selected for inclusion in this review, comprising a total of 379 patients. <h3>Results</h3> The six studies included were heterogeneous, comprising both retrospective and prospective designs, and were conducted across various countries and continents. The majority of patients were diagnosed with an ovarian IT and were thus female. In addition, the majority of ITs were classified as grade 3 and/or stage 1. Although, the treatment approach was predominantly surgical resection, five articles incorporated adjuvant chemotherapy for more advanced ITs. A total of 29 recurrences were documented between two- and 36-months post-treatment, with the highest incidence of recurrence occurring within the first year after treatment. Higher stage (stage II-III), higher grade (grade 3) and incomplete surgery were identified as risk factors for extracranial IT recurrence. The overall survival rates were excellent in all studies. Based on the findings our recommended follow-up guidelines are differentiated according to patients at risk and IT localisation. <h3>Conclusions</h3> This review offers insight into the risk factors associated with recurrence and provides recommendations for follow-up in paediatric extracranial IT patients. Further research is required to explore the identified associations for recurrence, with the aim of providing higher-level evidence that will further enhance the recommended follow-up regimen.
Pediatric palliative care in patients with brain tumors: Timing, activation, and management of acute events Olga Nigro, Marta Podda, Elisabetta Schiavello, Veronica Biassoni, Roberto Luksch, Monica Terenziani, Andrea Ferrari, Filippo Spreafico, Michela Casanova, Cristina Meazza, Stefano Chiaravalli, Nadia Puma, Luca Bergamaschi, Giovanna Gattuso, Giovanna Sironi, Valeria Colombo, Igor Catalano, Federico Pellegatta, Francesco Barretta, Sabina Vennarini, Giuseppe Forzini, Maura Massimino Tumori, 2025 Introduction: The highest percentage of our patients referred to Pediatric Palliative Care (PPC) are those with brain tumors. Of these, we analyzed PPC activation modes and timing, occurrence of acute events during the period of PPC activation, and the time between acute event and death. Methods During the period 1 January 2010 to 31 October 2023 approximately 1000 Cranial Nervous System (CNS) tumor patients were treated at Fondazione IRCCS Istituto Nazionale dei Tumori in Milan. All records of patients with CNS tumors who were treated and who died during this period were retrieved and retrospectively analyzed. Results: Data on 107 patients were retrieved. At the time of being taken over by PPC service, 32 patients were at diagnosis stage and 75 were beyond first-line of treatment. At diagnosis, 31 patients had already undergone surgery for placement of a ventriculoperitoneal shunt due to acute intracranial hypertension (IH). Twenty-nine out of 107 patients suffered an emergency while already managed by PPC service. In 18 out of 29 cases, emergency was an acute IH episode. Median time from diagnosis to PPC activation and from diagnosis to death (Overall Survival) were 12.1 months (6.2-27.3) and 16.7 months (10.8-31.1), respectively. Sixty-two patients died at home, 32 were admitted to and died in the referring hospice, 13 died in different hospitals. Conclusions: Management of a “complex” pediatric patient with an unfavorable prognosis requires early activation of PPC, with a seamless continuation of the already existing partnerships between family, pediatric-oncology team, referring neurosurgeon and palliative care teams.
Long-Term Remission of a Pediatric Vaginal Yolk Sac Tumor and Adult-Onset Recurrence Giovanna Gattuso, Monica Terenziani, Biagio Paolini, Valeria Colombo, Paola Collini, Francesco Raspagliesi, Maura Massimino, Antonino Ditto Pediatric Blood and Cancer, 2025 Data sharing is not applicable to this article as no new data were created or analyzed in this study.
Malignant Peripheral Nerve Sheath Tumor in Children and Adolescents: Local Treatment in a Retrospective Single-Center Experience Andrea Ferrari, Luca Bergamaschi, Stefano Chiaravalli, Marco Fiore, Chiara Colombo, Emilia Pecori, Arianna Trovò, Carlo Morosi, Roberto Luksch, Monica Terenziani, Filippo Spreafico, Cristina Meazza, Marta Podda, Veronica Biassoni, Elisabetta Schiavello, Nadia Puma, Giovanna Gattuso, Giovanna Sironi, Olga Nigro, Valeria Colombo, Patrizia Gasparini, Sandro Pasquali, Maura Massimino, Michela Casanova, Sabina Vennarini Pediatric Blood and Cancer, 2025 BackgroundMalignant peripheral nerve sheath tumor (MPNST) is a rare and aggressive sarcoma often associated with neurofibromatosis type 1, whose clinical management remains complex and challenging. Few publications exist on pediatric MPNST, and limited data are available on the best treatment approach, in particular regarding local therapy.MethodsThis retrospective analysis concerned 45 patients less than 18 years old with MPNST, treated at a referral center for pediatric sarcomas from 1983 to 2023. Patients were treated using a multimodal approach, based on the protocols adopted at the time of their diagnosis.ResultsFor the series as a whole, the median event‐free survival (EFS) and overall survival (OS) were 16 and 26 months, respectively, and 5‐year EFS and OS were 28.8% and 40.1%. The first event was local failure in 18 cases, local failure plus metastases in nine cases, and metastases‐only in four cases. At univariable analysis, survival was better for males and patients younger than 15 years, and was influenced by tumor invasiveness and tumor size. With regard to treatment modalities, survival rates were significantly better for patients who responded to chemotherapy; EFS, local relapse‐free survival (LRFS), and OS were better for patients who had a surgical resection; EFS and LRFS were better for patients who received radiotherapy combined with surgery, while OS was better for patients who had R0 resection.ConclusionsOur study confirmed the unsatisfactory outcome of MPNST pediatric patients. Our series would suggest that a combined local treatment that included both surgical resection and radiotherapy could improve local control.
Pediatric Craniofacial Osteosarcoma: The Milano Experience Cristina Meazza, Francesca Parisi, Francesco Barretta, Giovanna Sironi, Olga Nigro, Carlo Morosi, Roberto Luksch, Marta Podda, Andrea Ferrari, Monica Terenziani, Filippo Spreafico, Michela Casanova, Veronica Biassoni, Elisabetta Schiavello, Antonina Parafioriti, Paola Collini, Stefano Chiaravalli, Nadia Puma, Luca Bergamaschi, Giovanna Gattuso, Valeria Colombo, Sabina Vennarini, Emilia Pecori, Marco Guzzo, Sarah Colombo, Arianna Trovò, Maura Massimino Pediatric Blood and Cancer, 2025 BackgroundCraniofacial osteosarcoma (CFOS) is a rare tumor, typically affecting patients over 60, with a low incidence of metastasis at diagnosis as well as at relapse.Patients and methodsThis study analyzed patients treated for high‐grade CFOS at Fondazione IRCCS Istituto Nazionale dei Tumori between 1991 and 2021, focusing on histological characteristics, systemic and local treatment, and outcome.ResultsEleven patients (7F/4M) were included, with a median age of 15 years. Eight patients had an unfavorable site of origin (maxilla, cranial fossae, skull), seven had an unfavorable histology (i.e., chondroblastic subtype), and four had a high‐grade tumor (G4). Five had both unfavorable histology and primary tumor site, and three of the five a G4 tumor. Chemotherapy (MAP or MAPI regimen) was administered to all, with five receiving neoadjuvant treatment. Surgery was performed on all, achieving clear margins in eight patients (four of them had received neoadjuvant CT). Two of three patients with R1 surgery received adjuvant radiotherapy (RT) and are still alive and disease‐free. Three patients died of relapse, all with unfavorable primary tumor sites, G4 tumors, and two with unfavorable histology; one patient with positive margins had not received RT. At a median follow‐up of 65.8 months, 5‐year PFS was 100% for favorable tumor sites, 50% for unfavorable sites, and 85% for G3 tumors compared to 25% for G4 tumors.ConclusionUnfavorable tumor sites and G4 tumors may be indicative of a worse prognosis, especially as all relapsed patients had both. RT should be considered for R1 surgery. Due to the disease's rarity and complexity, specialized centers with expertise in head and neck sarcoma are essential for managing these patients.
Nephrotoxicity Surveillance for Childhood and Young Adult Survivors of Cancer: Recommendations From the International Late Effects of Childhood Cancer Guideline Harmonization Group Esmee C.M. Kooijmans, Renée L. Mulder, Stephen D. Marks, Vesna Pavasovic, Shveta S. Motwani, Thomas Walwyn, Nicholas G. Larkins, Jarmila Kruseova, Louis S. Constine, W. Hamish Wallace, Daniel M. Green, Arend Bökenkamp, Helena J.H. van der Pal, Marry M. van den Heuvel-Eibrink, Lars Hjorth, Liv Andrés-Jensen, Edit Bardi, Elvira C. van Dalen, Charlotte Demoor-Goldschmidt, Kerri Becktell, Marika Grönroos, Kathleen Kieran, Denitza Mironova, Monica Terenziani, Margreet A. Veening, Jakub Zieg, Songul Onder, Ali Mirza Onder, Jonathan C. Routh, Joel Thompson, Melissa M. Hudson, Leontien C.M. Kremer, Roderick Skinner, Matthew J. Ehrhardt Journal of Clinical Oncology, 2025 PURPOSE Childhood, adolescent, and young adult (CAYA) survivors of cancer are at risk of nephrotoxicity. Surveillance guidelines are important for timely diagnosis and treatment of these survivors, which could slow the progression to higher stages of kidney dysfunction. METHODS The International Late Effects of Childhood Cancer Guideline Harmonization Group established a multidisciplinary panel of 34 experts from 11 countries. The panel performed systematic literature reviews for articles published between 1990 and June 2023, graded the evidence using Grading of Recommendations Assessment, Development, and Evaluation methodology, and formulated recommendations based on evidence, clinical judgment, and consideration of benefits and harms of surveillance. Recommendations were critically appraised by two independent external experts and patient representatives. RESULTS Glomerular dysfunction surveillance is recommended every 2-5 years for survivors treated with ifosfamide, cisplatin, abdominal radiotherapy, total body irradiation, or nephrectomy and is reasonable after carboplatin treatment. We recommend screening for glomerular dysfunction using an estimated glomerular filtration rate (eGFR) equation that includes serum creatinine, preferably combined with serum cystatin C if available. Tubular dysfunction surveillance is recommended once at entry into long-term follow-up and with follow-up as clinically indicated for survivors treated with ifosfamide and is reasonable after cisplatin treatment. CONCLUSION These recommendations inform routine, uniform long-term follow-up care for CAYA survivors of cancer at risk of nephrotoxicity.
Metabolic syndrome in childhood, adolescent, and young adult cancer survivors: recommendations for surveillance from the International Late Effects of Childhood Cancer Guideline Harmonization Group Selina R van den Oever, Renée L Mulder, Kevin C Oeffinger, Jourik A Gietema, Roderick Skinner, Louis S Constine, W Hamish Wallace, Saro Armenian, Dana Barnea, Edit Bardi, Fabiën N Belle, Austin L Brown, Wassim Chemaitilly, Liz Crowne, Elvira C van Dalen, Christian Denzer, Matthew J Ehrhardt, Francesco Felicetti, Danielle N Friedman, Joy Fulbright, Adam W Glaser, Aleksander Giwercman, Hege Sangstuen Haugnes, Samah Hayek, Ulrike Hennewig, Marry M van den Heuvel-Eibrink, Riccardo Haupt, Laura van Iersel, Kala Kamdar, Joop Lefrandt, Gill Levitt, Vera Morsellino, Daniel A Mulrooney, Robert D Murray, Sebastian Neggers, Kirsten K Ness, Kristen A Neville, Nora L Nock, Maria Otth, Pinki K Prasad, Hanneke M van Santen, Christina Schindera, Shoshana R Rath, Julia Steinberger, Monica Terenziani, Mitra Varedi, Thomas Walwyn, Christina Wei, Melissa M Hudson, Leontien C M Kremer, Janine Nuver, Emily Tonorezos European Journal of Endocrinology, 2025
Foreign patients and multicultural challenges in pediatric oncology: The experience of the Istituto Nazionale dei Tumori in Milan Martina Lombardi, Matteo Silva, Monica Giovanetti, Daniele Cabibbe, Roberto Luksch, Monica Terenziani, Michela Casanova, Filippo Spreafico, Cristina Meazza, Marta Podda, Veronica Biassoni, Elisabetta Schiavello, Stefano Chiaravalli, Nadia Puma, Luca Bergamaschi, Giovanna Gattuso, Olga Nigro, Giovanna Sironi, Valeria Colombo, Andrea Ferrari, Maura Massimino, Carlo Alfredo Clerici Pediatric Blood and Cancer, 2024
Radiation Doses Received by Major Organs at Risk in Children and Young Adolescents Treated for Cancer with External Beam Radiation Therapy: A Large-scale Study from 12 European Countries Ibrahima Diallo, Rodrigue S. Allodji, Cristina Veres, Stéphanie Bolle, Damien Llanas, Safaa Ezzouhri, Wael Zrafi, Ghazi Debiche, Vincent Souchard, Romain Fauchery, Nadia Haddy, Neige Journy, Charlotte Demoor-Goldschmidt, David L. Winter, Lars Hjorth, Thomas Wiebe, Riccardo Haupt, Charlotte Robert, Leontien Kremer, Edit Bardi, Carlotta Sacerdote, Monica Terenziani, Claudia E. Kuehni, Christina Schindera, Roderick Skinner, Jeanette Falck Winther, Päivi Lähteenmäki, Julianne Byrn, Zsuzsanna Jakab, Elisabeth Cardis, Elisa Pasqual, Soile Tapio, Sarah Baatout, Mike Atkinson, Mohammed Abderrafi Benotmane, Elaine Sugden, Lorna Zadravec Zaletel, Cecile Ronckers, Raoul C. Reulen, Mike M. Hawkins, Florent de Vathaire International Journal of Radiation Oncology Biology Physics, 2024
Caring for children with cancer evacuated from Ukraine: The patients’ perception Marcello Bolognese, Maura Massimino, Daniele Cabibbe, Marco Zecca, Marta Fornara, Mariangela Armiraglio, Roman Kyzima, Roberto Luksch, Monica Terenziani, Michela Casanova, Filippo Spreafico, Cristina Meazza, Marta Podda, Veronica Biassoni, Elisabetta Schiavello, Stefano Chiaravalli, Nadia Puma, Shushan Hovsepyan, Luca Bergamaschi, Giovanna Gattuso, Olga Nigro, Paolo Grampa, Annarita Adduci, Andrea Ferrari, Carlo Alfredo Clerici Pediatric Blood and Cancer, 2024
Risk of subsequent gliomas and meningiomas among 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study Emma J. Heymer, Michael M. Hawkins, David L. Winter, Jop C. Teepen, Ceren Sunguc, Cécile M. Ronckers, Rodrigue S. Allodji, Daniela Alessi, Elaine Sugden, Fabiën N. Belle, Francesca Bagnasco, Julianne Byrne, Edit Bárdi, Stanislaw Garwicz, Desiree Grabow, Momcilo Jankovic, Peter Kaatsch, Melanie Kaiser, Gisela Michel, Christina Schindera, Nadia Haddy, Neige Journy, Maja Česen Mazić, Roderick Skinner, Judith L. Kok, Maria W. Gunnes, Thomas Wiebe, Carlotta Sacerdote, Milena M. Maule, Monica Terenziani, Zsuzsanna Jakab, Jeanette F. Winther, Päivi M. Lähteenmäki, Lorna Zadravec Zaletel, Riccardo Haupt, Claudia E. Kuehni, Leontien C. Kremer, Florent de Vathaire, Lars Hjorth, Raoul C. Reulen British Journal of Cancer, 2024
Cumulative Absolute Risk of Subsequent Colorectal Cancer After Abdominopelvic Radiotherapy Among Childhood Cancer Survivors: A PanCareSurFup Study Emma J. Heymer, Katarzyna Jóźwiak, Leontien C. Kremer, David L. Winter, Florent de Vathaire, Ceren Sunguc, Elaine Sugden, Judith L. Kok, Helena J.H. van der Pal, Lars Hjorth, Zsuzsanna Jakab, Milena M. Maule, Riccardo Haupt, Francesca Bagnasco, Monica Terenziani, Ibrahima Diallo, Maria W. Gunnes, Grit Sommer, Lorna Zadravec Zaletel, Claudia E. Kuehni, Jeanette F. Winther, Päivi M. Lähteenmäki, Thorgerdur Gudmundsdottir, Rodrigue S. Allodji, Roderick Skinner, Cécile M. Ronckers, Michael M. Hawkins, Raoul C. Reulen, Jop C. Teepen Journal of Clinical Oncology, 2024
Current practices of follow-up programs for childhood cancer survivors in Italy Monica Terenziani, Alberto Eugenio Tozzi, Laura Diaco, Eleonora Biasin, Alessandro Cattoni, Ileana Croci, Donatella Fraschini, Giovanna Giorgiani, Riccardo Haupt, Monica Muraca, Marta Pillon, Giovanna Sironi, Maria Grazia Valsecchi, Angela Mastronuzzi Tumori, 2023
Risk Factors for Primary Bone Cancer after Childhood Cancer: A PanCare Childhood and Adolescent Cancer Survivor Care and Follow-Up Studies Nested Case-Control Study Raoul C. Reulen, David L. Winter, Ibrahim Diallo, Cristina Veres, Damien Llanas, Rodrigue S. Allodji, Francesca Bagnasco, Edit Bárdi, Elizabeth A.M. Feijen, Daniela Alessi, Miranda M. Fidler-Benaoudia, Stine Høgsholt, Jop C. Teepen, Helena Linge, Nadia Haddy, Julianne Byrne, Ghazi Debiche, Desiree Grabow, Thorgerdur Gudmundsdottir, Romain Fauchery, Wael Zrafi, Gisela Michel, Hilde Øfstaas, Peter Kaatsch, Giao Vu-Bezin, Helen Jenkinson, Melanie Kaiser, Roderick Skinner, Trevor Cole, Nicolas Waespe, Grit Sommer, Susanne Nordenfelt, Momcilo Jankovic, Tuomas Lähteenmäki Taalas, Milena M. Maule, Helena J.H. van der Pal, Cécile M. Ronckers, Flora E. van Leeuwen, Judith L. Kok, Monica Terenziani, Maria Winther Gunnes, Thomas Wiebe, Carlotta Sacerdote, Zsuzsanna Jakab, Riccardo Haupt, Päivi M. Lähteenmäki, Lorna Zadravec Zaletel, Claudia E. Kuehni, Jeanette F. Winther, Leontien C.M. Kremer, Lars Hjorth, Florent de Vathaire, Michael M. Hawkins Journal of Clinical Oncology, 2023
Risk of subsequent primary lymphoma in a cohort of 69,460 five-year survivors of childhood and adolescent cancer in Europe: The PanCareSurFup study Isabelle M. Dudley, Ceren Sunguc, Emma J. Heymer, David L. Winter, Jop C. Teepen, Fabiën N. Belle, Edit Bárdi, Francesca Bagnasco, Thorgerdur Gudmundsdottir, Roderick Skinner, Gisela Michel, Julianne Byrne, Hilde Øfstaas, Momcilo Jankovic, Maja Česen Mazić, Luzius Mader, Jaqueline Loonen, Stanislaw Garwicz, Thomas Wiebe, Daniela Alessi, Rodrigue S. Allodji, Nadia Haddy, Desiree Grabow, Peter Kaatsch, Melanie Kaiser, Milena M. Maule, Zsuzsanna Jakab, Maria Winther Gunnes, Monica Terenziani, Lorna Zadravec Zaletel, Claudia E. Kuehni, Riccardo Haupt, Florent de Vathaire, Leontien C. Kremer, Päivi M. Lähteenmäki, Jeanette F. Winther, Lars Hjorth, Michael M. Hawkins, Raoul C. Reulen Cancer, 2023
Risk of subsequent primary oral cancer in a cohort of 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study Ceren Sunguc, Michael M. Hawkins, David L. Winter, Isabelle M. Dudley, Emma J. Heymer, Jop C. Teepen, Rodrigue S. Allodji, Fabiën N. Belle, Francesca Bagnasco, Julianne Byrne, Edit Bárdi, Cécile M. Ronckers, Nadia Haddy, Thorgerdur Gudmundsdottir, Stanislaw Garwicz, Momcilo Jankovic, Helena J. H. van der Pal, Maja Česen Mazić, Christina Schindera, Desiree Grabow, Milena M. Maule, Peter Kaatsch, Melanie Kaiser, Brice Fresneau, Gisela Michel, Roderick Skinner, Thomas Wiebe, Carlotta Sacerdote, Zsuzsanna Jakab, Maria Winther Gunnes, Monica Terenziani, Jeanette F. Winther, Päivi M. Lähteenmäki, Lorna Zadravec Zaletel, Claudia E. Kuehni, Leontien C. Kremer, Riccardo Haupt, Florent de Vathaire, Lars Hjorth, Raoul C. Reulen British Journal of Cancer, 2023
Genome-wide analyses of platinum-induced ototoxicity in childhood cancer patients: Results of GO-CAT and United Kingdom MAGIC consortia Evelien G. E. Hurkmans, Marije J. Klumpers, Cinzia Dello Russo, Ward De Witte, Henk-Jan Guchelaar, Hans Gelderblom, Anne-Marie Cleton-Jansen, Sita H. Vermeulen, Suzanne Kaal, Winette T. A. van der Graaf, Uta Flucke, Corrie E. M. Gidding, Hendrik W. B. Schreuder, Eveline S. J. M. de Bont, Huib N. Caron, Giovanna Gattuso, Elisabetta Schiavello, Monica Terenziani, Maura Massimino, Geoff McCowage, Sumanth Nagabushan, Anuja Limaye, Victoria Rose, Daniel Catchpoole, Andrea L. Jorgensen, Christopher Barton, Lucy Delaney, Daniel B. Hawcutt, Munir Pirmohamed, Barry Pizer, Marieke J. H. Coenen, D. Maroeska W. M. te Loo Frontiers in Pharmacology, 2023
Adolescents and young adults with cancer: Surfing the web to know and manage their disease Annarita Adduci, Paolo Grampa, Francesco Barretta, Giovanna Sironi, Matteo Silva, Roberto Luksch, Monica Terenziani, Michela Casanova, Filippo Spreafico, Cristina Meazza, Marta Podda, Veronica Biassoni, Elisabetta Schiavello, Stefano Chiaravalli, Carlo Alfredo Clerici, Maura Massimino, Andrea Ferrari Ejc Paediatric Oncology, 2023
Relapse after nonmetastatic rhabdomyosarcoma: Salvage rates and prognostic variables Luca Bergamaschi, Stefano Chiaravalli, Virginia Livellara, Giovanna Sironi, Nadia Puma, Olga Nigro, Giovanna Gattuso, Roberto Luksch, Monica Terenziani, Filippo Spreafico, Cristina Meazza, Marta Podda, Veronica Biassoni, Elisabetta Schiavello, Shushan Hovsepyan, Carlo Morosi, Sabina Vennarini, Maura Massimino, Michela Casanova, Andrea Ferrari Pediatric Blood and Cancer, 2023
Secondary osteosarcoma: a challenge indeed Cristina Meazza, Sironi Giovanna, Olga Nigro, Giovanna Gattuso, Barretta Francesco, Marta Podda, Roberto Luksch, Veronica Biassoni, Elisabetta Schiavello, Andrea Ferrari, Filippo Spreafico, Michela Casanova, Stefano Chiaravalli, Nadia Puma, Luca Bergamaschi, Virginia Livellara, Morosi Carlo, Antonina Parafioriti, Primo Daolio, Stefano Bastoni, Sabina Vennarini, Emilia Pecori, Ombretta Alessandro, Paola Collini, Maura Massimino, Monica Terenziani International Journal of Clinical Oncology, 2023
Get up, stand up: Alongside adolescents and young adults with cancer for their right to be forgotten Paola Quarello, Angela Toss, Maurizio Mascarin, Giuseppe Luigi Banna, Marta Canesi, Giuseppe Maria Milano, Lorena Incorvaia, Matteo Lambertini, Monica Terenziani, Carlo Alfredo Clerici, Giulio Enea Vigevani, Giordano Domenico Beretta, Arcangelo Prete, Saverio Cinieri, Fedro Alessandro Peccatori, Andrea Ferrari Tumori, 2022
Ultra Short Course Chemotherapy for Early-Stage Non-Hodgkin’s Lymphoma in Children Elisabetta Schiavello, Filippo Spreafico, Francesco Barretta, Giulia Meraviglia, Veronica Biassoni, Monica Terenziani, Luna Boschetti, Giovanna Gattuso, Stefano Chiaravalli, Luca Bergamaschi, Nadia Puma, Giovanna Sironi, Olga Nigro, Marta Podda, Cristina Meazza, Michela Casanova, Andrea Ferrari, Roberto Luksch, Maura Massimino Children, 2022
How ten-years of reirradiation for paediatric high-grade glioma may shed light on first line treatment Maura Massimino, Sabina Vennarini, Francesco Barretta, Francesca Colombo, Manila Antonelli, Bianca Pollo, Emanuele Pignoli, Emilia Pecori, Ombretta Alessandro, Elisabetta Schiavello, Luna Boschetti, Marta Podda, Nadia Puma, Giovanna Gattuso, Giovanna Sironi, Elena Barzanò, Olga Nigro, Luca Bergamaschi, Stefano Chiaravalli, Roberto Luksch, Cristina Meazza, Filippo Spreafico, Monica Terenziani, Michela Casanova, Andrea Ferrari, Marco Chisari, Chiara Pellegrini, Carlo Alfredo Clerici, Piergiorgio Modena, Veronica Biassoni Journal of Neuro Oncology, 2022
Caring for children with cancer evacuated from Ukraine Maura Massimino, Giovanna Casiraghi, Mariangela Armiraglio, Daniele Cabibbe, Roberto Luksch, Monica Terenziani, Michela Casanova, Filippo Spreafico, Cristina Meazza, Marta Podda, Veronica Biassoni, Elisabetta Schiavello, Stefano Chiaravalli, Nadia Puma, Luca Bergamaschi, Giovanna Gattuso, Giovanna Sironi, Olga Nigro, Virginia Livellara, Shushan Hovsepyan, Andrea Ferrari, Carlo Alfredo Clerici Lancet Child and Adolescent Health, 2022
Extraosseous Ewing sarcoma in children and adolescents: A retrospective series from a referral pediatric oncology center Virginia Livellara, Luca Bergamaschi, Nadia Puma, Stefano Chiaravalli, Marta Podda, Michela Casanova, Patrizia Gasparini, Emilia Pecori, Ombretta Alessandro, Olga Nigro, Giovanna Sironi, Giovanna Gattuso, Monica Terenziani, Filippo Spreafico, Cristina Meazza, Veronica Biassoni, Elisabetta Schiavello, Maura Massimino, Roberto Luksch, Andrea Ferrari Pediatric Blood and Cancer, 2022
Managing Care during the COVID-19 Pandemic: The Point of View and Fears of Pediatric Cancer Patients’ Families Olga Nigro, Giovanna Sironi, Andrea Ferrari, Gabriele Tinè, Gabriele Infante, Francesco Barretta, Matteo Silva, Carlo Alfredo Clerici, Stefano Chiaravalli, Elisabetta Schiavello, Veronica Biassoni, Marta Podda, Cristina Meazza, Filippo Spreafico, Michela Casanova, Monica Terenziani, Roberto Luksch, Maura Massimino Children, 2022
Male breast cancer after childhood cancer: Systematic review and analyses in the PanCareSurFup cohort Yuehan Wang, Raoul C. Reulen, Leontien C.M. Kremer, Florent de Vathaire, Riccardo Haupt, Lorna Zadravec Zaletel, Francesca Bagnasco, Charlotte Demoor-Goldschmidt, Willem J. van Dorp, Nadia Haddy, Lars Hjorth, Zsuzsanna Jakab, Claudia E. Kuehni, Päivi M. Lähteenmäki, Helena J.H. van der Pal, Carlotta Sacerdote, Roderick Skinner, Monica Terenziani, Finn Wesenberg, Jeanette F. Winther, Flora E. van Leeuwen, Mike M. Hawkins, Jop C. Teepen, Elvira C. van Dalen, Cécile M. Ronckers European Journal of Cancer, 2022
Fertility counseling in women with hereditary cancer syndromes Edgardo Somigliana, Maria Paola Costantini, Francesca Filippi, Monica Terenziani, Alessandra Riccaboni, Valeria Nicotra, Rocco Rago, Alessio Paffoni, Luca Mencaglia, Stefania Magnolfi, Daniela Zuccarello, Laura Rienzi, Francesca Spinella, Antonio Capalbo, Giulia Scaravelli, Salvo Testa Critical Reviews in Oncology Hematology, 2022
Langerhans cell histiocytosis in adults: a retrospective, single-center case series Stefano Chiaravalli, Andrea Ferrari, Luca Bergamaschi, Nadia Puma, Giovanna Gattuso, Giovanna Sironi, Olga Nigro, Virginia Livellara, Elisabetta Schiavello, Veronica Biassoni, Marta Podda, Cristina Meazza, Filippo Spreafico, Michela Casanova, Monica Terenziani, Roberto Luksch, Maura Massimino Annals of Hematology, 2022
Impact of era of diagnosis on cause-specific late mortality among 77 423 five-year European survivors of childhood and adolescent cancer: The PanCareSurFup consortium Julianne Byrne, Irene Schmidtmann, Humayra Rashid, Oskar Hagberg, Francesca Bagnasco, Edit Bardi, Florent De Vathaire, Samira Essiaf, Jeanette Falck Winther, Eva Frey, Thorgerdur Gudmundsdottir, Riccardo Haupt, Michael M. Hawkins, Zsuzsanna Jakab, Momcilo Jankovic, Peter Kaatsch, Leontien C. M. Kremer, Claudia E. Kuehni, Arja Harila‐Saari, Gill Levitt, Raoul Reulen, Cécile M. Ronckers, Milena Maule, Roderick Skinner, Eva Steliarova‐Foucher, Monica Terenziani, Lorna Zadravec Zaletel, Lars Hjorth, Stanislaw Garwicz, Desiree Grabow International Journal of Cancer, 2022
Adolescents with cancer on privacy: Fact-finding survey on the need for confidentiality and space Matteo Silva, Francesco Barretta, Roberto Luksch, Monica Terenziani, Michela Casanova, Filippo Spreafico, Cristina Meazza, Marta Podda, Veronica Biassoni, Elisabetta Schiavello, Stefano Chiaravalli, Nadia Puma, Luca Bergamaschi, Giovanna Gattuso, Giovanna Sironi, Annarita Adduci, Paolo Grampa, Maura Massimino, Andrea Ferrari Tumori, 2021
Risk of digestive cancers in a cohort of 69 460 five-year survivors of childhood cancer in Europe: The PanCareSurFup study Raoul C Reulen, Kwok F Wong, Chloe J Bright, David L Winter, Daniela Alessi, Rodrigue M Allodji, Francesca Bagnasco, Edit Bárdi, Andrea Bautz, Julianne Byrne, Elizabeth AM Feijen, Miranda M Fidler-Benaoudia, Ibrahim Diallo, Stanislaw Garwicz, Desiree Grabow, Thorgerdur Gudmundsdottir, Joyeeta Guha, Nadia Haddy, Stine Høgsholt, Moncilo Jankovic, Peter Kaatsch, Melanie Kaiser, Rahel Kuonen, Helena Linge, Hilde Øfstaas, Cecile M Ronckers, Eva-Maria Hau, Roderick Skinner, Flora E van Leeuwen, Jop C Teepen, Cristina Veres, Wael Zrafi, Ghazi Debiche, Damien Llanas, Monica Terenziani, Giao Vu-Bezin, Finn Wesenberg, Thomas Wiebe, Carlotta Sacerdote, Zsuzsanna Jakab, Riccardo Haupt, Päivi M Lähteenmäki, Lorna Zadravec Zaletel, Claudia E Kuehni, Jeanette F Winther, Florent de Vathaire, Leontien C Kremer, Lars Hjorth, Michael M Hawkins Gut, 2021
Sperm cryopreservation in adolescents with cancer Marco Reschini, Edgardo Somigliana, Cristina Meazza, Marta Podda, Cristina Guarneri, Daniela Giacchetta, Maura Massimino, Liliana Restelli, Francesca Filippi, Monica Terenziani European Journal of Obstetrics and Gynecology and Reproductive Biology, 2021
Medulloblastoma and familial adenomatous polyposis: Good prognosis and good quality of life in the long-term? Maura Massimino, Stefano Signoroni, Luna Boschetti, Luisa Chiapparini, Alessandra Erbetta, Veronica Biassoni, Elisabetta Schiavello, Andrea Ferrari, Filippo Spreafico, Monica Terenziani, Stefano Chiaravalli, Nadia Puma, Luca Bergamaschi, Maria Teresa Ricci, Laura Cattaneo, Giovanna Gattuso, Francesca Romana Buttarelli, Francesca Gianno, Evelina Miele, Geraldina Poggi, Marco Vitellaro Pediatric Blood and Cancer, 2021
Adolescents with Terminal Cancer: Making Good Use of Illusions Carlo Alfredo Clerici, Elena Pagani Bagliacca, Laura Veneroni, Marta Podda, Matteo Silva, Patrizia Gasparini, Roberto Luksch, Monica Terenziani, Michela Casanova, Filippo Spreafico, Cristina Meazza, Veronica Biassoni, Elisabetta Schiavello, Stefano Chiaravalli, Tullio Proserpio, Maura Massimino, Andrea Ferrari Journal of Adolescent and Young Adult Oncology, 2020
A collateral effect of the COVID-19 pandemic: Delayed diagnosis in pediatric solid tumors Stefano Chiaravalli, Andrea Ferrari, Giovanna Sironi, Giovanna Gattuso, Luca Bergamaschi, Nadia Puma, Elisabetta Schiavello, Veronica Biassoni, Marta Podda, Cristina Meazza, Filippo Spreafico, Michela Casanova, Monica Terenziani, Roberto Luksch, Maura Massimino Pediatric Blood and Cancer, 2020
SARS-CoV-2 disease and children under treatment for cancer Monica Terenziani, Maura Massimino, Veronica Biassoni, Michela Casanova, Stefano Chiaravalli, Andrea Ferrari, Roberto Luksch, Cristina Meazza, Marta Podda, Elisabetta Schiavello, Filippo Spreafico Pediatric Blood and Cancer, 2020
Cancer treatment in disabled children Cristina Meazza, Elisabetta Schiavello, Veronica Biassoni, Marta Podda, Chiara Barteselli, Francesco Barretta, Giovanna Gattuso, Monica Terenziani, Andrea Ferrari, Filippo Spreafico, Roberto Luksch, Michela Casanova, Stefano Chiaravalli, Nadia Puma, Luca Bergamaschi, Maura Massimino European Journal of Pediatrics, 2020
Secreting germ cell tumors of the central nervous system: A long-term follow-up experience Veronica Biassoni, Elisabetta Schiavello, Lorenza Gandola, Emilia Pecori, Geraldina Poggi, Filippo Spreafico, Monica Terenziani, Cristina Meazza, Marta Podda, Andrea Ferrari, Roberto Luksch, Michela Casanova, Nadia Puma, Stefano Chiaravalli, Luca Bergamaschi, Graziella Cefalo, Fabio Simonetti, Giovanna Gattuso, Ettore Cesare Seregni, Federica Pallotti, Francesca Gianno, Barbara Diletto, Francesco Barretta, Maura Massimino Cancers, 2020
Children with cancer in the time of COVID-19: An 8-week report from the six pediatric onco-hematology centers in Lombardia, Italy Andrea Ferrari, Marco Zecca, Carmelo Rizzari, Fulvio Porta, Massimo Provenzi, Maddalena Marinoni, Richard Fabian Schumacher, Roberto Luksch, Monica Terenziani, Michela Casanova, Filippo Spreafico, Stefano Chiaravalli, Francesca Compagno, Federica Bruni, Chiara Piccolo, Laura Bettini, Mariella D'Angiò, Giulia Maria Ferrari, Andrea Biondi, Maura Massimino, Adriana Balduzzi Pediatric Blood and Cancer, 2020
How young patients with cancer perceive the COVID-19 (coronavirus) epidemic in Milan, Italy: Is there room for other fears? Michela Casanova, Elena Pagani Bagliacca, Matteo Silva, Carlo Patriarca, Laura Veneroni, Carlo Alfredo Clerici, Filippo Spreafico, Roberto Luksch, Monica Terenziani, Cristina Meazza, Marta Podda, Veronica Biassoni, Elisabetta Schiavello, Stefano Chiaravalli, Nadia Puma, Luca Bergamaschi, Giovanna Gattuso, Giovanna Sironi, Maura Massimino, Andrea Ferrari Pediatric Blood and Cancer, 2020
Reduced-dose craniospinal irradiation is feasible for standard-risk adult medulloblastoma patients Maura Massimino, Marie Pierre Sunyach, Francesco Barretta, Lorenza Gandola, Anna Garegnani, Emilia Pecori, Filippo Spreafico, Alice Bonneville-Levard, David Meyronet, Carmine Mottolese, Luna Boschetti, Veronica Biassoni, Elisabetta Schiavello, Carlo Giussani, Giorgio Carrabba, Barbara Diletto, Federica Pallotti, Roberto Stefini, Andrea Ferrari, Monica Terenziani, Michela Casanova, Roberto Luksch, Cristina Meazza, Marta Podda, Stefano Chiaravalli, Nadia Puma, Luca Bergamaschi, Carlo Morosi, Giuseppina Calareso, Felice Giangaspero, Manila Antonelli, Francesca Romana Buttarelli, Didier Frappaz Journal of Neuro Oncology, 2020
Investigating sexuality in adolescents with cancer: patients talk of their experiences Laura Veneroni, Elena Pagani Bagliacca, Giovanna Sironi, Matteo Silva, Michela Casanova, Luca Bergamaschi, Monica Terenziani, Jessica Trombatore, Carlo Alfredo Clerici, Antonio Prunas, Marco Silvaggi, Maura Massimino, Andrea Ferrari Pediatric Hematology and Oncology, 2020
Risk of subsequent primary leukaemias among 69,460 five-year survivors of childhood cancer diagnosed from 1940 to 2008 in Europe: A cohort study within PanCareSurFup Rodrigue S. Allodji, Mike M. Hawkins, Chloe J. Bright, Miranda M. Fidler-Benaoudia, David L. Winter, Daniela Alessi, Brice Fresneau, Neige Journy, Vera Morsellino, Edit Bárdi, Andrea Bautz, Julianne Byrne, Elizabeth (Lieke) AM. Feijen, Jop C. Teepen, Giao Vu-Bezin, Carole Rubino, Stanislaw Garwicz, Desiree Grabow, Thorgerdur Gudmundsdottir, Joyeeta Guha, Eva-Maria Hau, Momcilo Jankovic, Peter Kaatsch, Melanie Kaiser, Helena Linge, Monica Muraca, Damien Llanas, Cristina Veres, Hilde Øfstaas, Ibrahima Diallo, Imene Mansouri, Cecile M. Ronckers, Roderick Skinner, Monica Terenziani, Finn Wesenberg, Thomas Wiebe, Carlotta Sacerdote, Zsuzsanna Jakab, Riccardo Haupt, Päivi Lähteenmäki, Lorna Zadravec Zaletel, Claudia E. Kuehni, Jeanette F. Winther, Gisela Michel, Leontien C.M. Kremer, Lars Hjorth, Nadia Haddy, Florent de Vathaire, Raoul C. Reulen European Journal of Cancer, 2019
Late mortality and causes of death among 5-year survivors of childhood cancer diagnosed in the period 1960–1999 and registered in the Italian Off-Therapy Registry Francesca Bagnasco, Silvia Caruso, Anita Andreano, Maria Grazia Valsecchi, Momcilo Jankovic, Andrea Biondi, Lucia Miligi, Claudia Casella, Monica Terenziani, Maura Massimino, Carlotta Sacerdote, Vera Morsellino, Giovanni Erminio, Alberto Garaventa, Maura Faraci, Concetta Micalizzi, Maria Luisa Garrè, Marta Pillon, Giuseppe Basso, Eleonora Biasin, Franca Fagioli, Roberto Rondelli, Andrea Pession, Franco Locatelli, Nicola Santoro, Paolo Indolfi, Giovanna Palumbo, Giovanna Russo, Federico Verzegnassi, Claudio Favre, Marco Zecca, Rossella Mura, Paolo D'Angelo, Carmen Cano, Julianne Byrne, Riccardo Haupt, Julianne Byrne, Riccardo Haupt, Paolo Pierani, Nicola Santoro, Andreea Pession, Fulvio Porta, Rossella Mura, Giovanna Russo, Caterina Consarino, Roberta Burnelli, Claudio Favre, Maria Luisa Garrè, Fausto Fedeli, Maura Massimino, Maura Massimino, Monica Cellini, Andrea Biondi, Fiorina Casale, Giuseppe Menna, Giuseppe Basso, Paolo D'Angelo, Patrizia Bertolini, Marco Zecca, Maurizio Caniglia, Valerio Cecinati, Gabriella Casazza, Roberto Foà, Anna Clerico, Franco Locatelli, Saverio Ladogana, Daniela Galimberti, Franca Fagioli, Marco Rabusin, Luigi Nespoli, Simone Cesaro European Journal of Cancer, 2019
Long-term survivors of childhood cancer: cure and care—the Erice Statement (2006) revised after 10 years (2016) participants in PanCare, Momcilo Jankovic, Riccardo Haupt, John J. Spinetta, Joern D. Beck, Julianne Byrne, Gabriele Calaminus, Herwig Lackner, Andrea Biondi, Kevin Oeffinger, Melissa Hudson, Roderick Skinner, Gregory Reaman, Helena van der Pal, Leontien Kremer, Jaap den Hartogh, Gisela Michel, Eva Frey, Edit Bardi, Michael Hawkins, Katie Rizvi, Monica Terenziani, Maria Grazia Valsecchi, Gerlind Bode, Meriel Jenney, Florent de Vathaire, Stanislaw Garwicz, Gill A. Levitt, Desiree Grabow, Claudia E. Kuehni, Martin Schrappe, Lars Hjorth Journal of Cancer Survivorship, 2018
Genetic and epigenetic analyses guided by high resolution whole-genome SNP array reveals a possible role of CHEK2 in Wilms tumour susceptibility Oncotarget, 2018
Primary metastatic osteosarcoma: results of a prospective study in children given chemotherapy and interleukin-2 Cristina Meazza, Graziella Cefalo, Maura Massimino, Primo Daolio, Ugo Pastorino, Paolo Scanagatta, Carlo Morosi, Marta Podda, Andrea Ferrari, Monica Terenziani, Filippo Spreafico, Michela Casanova, Antonina Parafioriti, Paola Collini, Lorenza Gandola, Stefano Bastoni, Veronica Biassoni, Elisabetta Schiavello, Stefano Chiaravalli, Nadia Puma, Luca Bergamaschi, Roberto Luksch Medical Oncology, 2017
Results of the Third AIEOP Cooperative Protocol on Wilms Tumor (TW2003) and Related Considerations Filippo Spreafico, Davide Biasoni, Salvatore Lo Vullo, Lorenza Gandola, Paolo D’Angelo, Monica Terenziani, Maurizio Bianchi, Massimo Provenzi, Paolo Indolfi, Andrea Pession, Marilina Nantron, Andrea Di Cataldo, Carlo Morosi, Daniela Perotti, Serena Catania, Franca Fossati Bellani, Paola Collini, and Journal of Urology, 2017
Searching for happiness Andrea Ferrari, Paola Gaggiotti, Matteo Silva, Laura Veneroni, Chiara Magni, Stefano Signoroni, Michela Casanova, Roberto Luksch, Monica Terenziani, Filippo Spreafico, Cristina Meazza, Carlo Alfredo Clerici, Maura Massimino Journal of Clinical Oncology, 2017
Measuring the efficacy of a project for adolescents and young adults with cancer: A study from the Milan Youth Project Andrea Ferrari, Matteo Silva, Laura Veneroni, Chiara Magni, Carlo Alfredo Clerici, Cristina Meazza, Monica Terenziani, Filippo Spreafico, Stefano Chiaravalli, Michela Casanova, Roberto Luksch, Serena Catania, Elisabetta Schiavello, Veronica Biassoni, Marta Podda, Luca Bergamaschi, Nadia Puma, Alice Indini, Tullio Proserpio, Maura Massimino Pediatric Blood and Cancer, 2016
Abdomen/pelvis computed tomography in staging of pediatric Hodgkin Lymphoma: is it always necessary? Piero Farruggia, Giuseppe Puccio, Alessandra Sala, Alessandra Todesco, Monica Terenziani, Rosamaria Mura, Salvatore D'Amico, Tommaso Casini, Clara Mosa, Marta Pillon, Maria Paola Boaro, Gaetano Bottigliero, Roberta Burnelli, Caterina Consarino, Fausto Fedeli, Maurizio Mascarin, Katia Perruccio, Elisabetta Schiavello, Angela Trizzino, Umberto Ficola, Alberto Garaventa, Mario Rossello Cancer Medicine, 2016
Clouds of oxygen: Adolescents With cancer tell their story in music Andrea Ferrari, Laura Veneroni, Carlo Alfredo Clerici, Michela Casanova, Stefano Chiaravalli, Chiara Magni, Roberto Luksch, Monica Terenziani, Filippo Spreafico, Daniela Polastri, Cristina Meazza, Serena Catania, Elisabetta Schiavello, Veronica Biassoni, Marta Podda, Luca Bergamaschi, Nadia Puma, Carla Moscheo, Giacomo Gotti, Maura Massimino Journal of Clinical Oncology, 2015
Mature and immature teratoma: A report from the second Italian pediatric study Monica Terenziani, Paolo D'Angelo, Alessandro Inserra, Renata Boldrini, Gianni Bisogno, Gian Luca Babbo, Massimo Conte, Patrizia Dall' Igna, Maria Debora De Pasquale, Paolo Indolfi, Luigi Piva, Giovanna Riccipetitoni, Fortunato Siracusa, Filippo Spreafico, Paolo Tamaro, Giovanni Cecchetto Pediatric Blood and Cancer, 2015
Survivorship after childhood cancer: PanCare: A European Network to promote optimal long-term care Lars Hjorth, Riccardo Haupt, Roderick Skinner, Desiree Grabow, Julianne Byrne, Sabine Karner, Gill Levitt, Gisela Michel, Helena van der Pal, Edit Bárdi, Jörn D. Beck, Florent de Vathaire, Stefan Essig, Eva Frey, Stanislaw Garwicz, Mike Hawkins, Zsuzsanna Jakab, Momcilo Jankovic, Bernarda Kazanowska, Tomas Kepak, Leontien Kremer, Herwig Lackner, Elaine Sugden, Monica Terenziani, Lorna Zadravec Zaletel, Peter Kaatsch European Journal of Cancer, 2015
Differences in sports participation for children and adolescents with solitary kidney due to renal tumors across Europe. Time for harmonization Minerva Pediatrica, 2015
Use of the word “cured” for cancer patients—implications for patients and physicians: The Siracusa charter P. Tralongo, L. Dal Maso, A. Surbone, A. Santoro, U. Tirelli, V. Sacchini, C. Pinto, S. Crispino, F. Ferraù, G. Mandoliti, G. Tonini, A. Russo, D. Santini, A. Madeddu, V. Panebianco, S. Pergolizzi, D. Respini, C. Rolfo, M. Bongiovanni, F. De Lorenzo, C. Spatola, F. Di Raimondo, M. Terenziani, M. Peeters, C. Castoro Current Oncology, 2015
Synchronous bilateral Wilms tumor: A report from the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) Paolo Indolfi, Alessandro Jenkner, Monica Terenziani, Alessandro Crocoli, Annalisa Serra, Paola Collini, Davide Biasoni, Lorenza Gandola, Gianni Bisogno, Giovanni Cecchetto, Martina Di Martino, Paolo D'Angelo, Maurizio Bianchi, Massimo Conte, Alessandro Inserra, Andrea Pession, Filippo Spreafico, on behalf of the AIEOP Wilms Tumor Working Group Cancer, 2013
Adolescents suffering from cancer: "Youth Project" of the National Cancer Institute of Milan Recenti Progressi in Medicina, 2013
Metastatic renal cell carcinoma in children and adolescents: A 30-year unsuccessful story Paolo Indolfi, Filippo Spreafico, Paola Collini, Giovanni Cecchetto, Fiorina Casale, Monica Terenziani, Amalia Schiavetti, Paolo Pierani, Luigi Piva, Daniela Cuzzubbo, Maria D. De Pasquale, Elvira Pota, Alessandro Inserra, Gianni Bisogno Journal of Pediatric Hematology Oncology, 2012
Genomic profiling by whole-genome single nucleotide polymorphism arrays in Wilms tumor and association with relapse Daniela Perotti, Filippo Spreafico, Federica Torri, Beatrice Gamba, Pio D'Adamo, Sara Pizzamiglio, Monica Terenziani, Serena Catania, Paola Collini, Marilina Nantron, Andrea Pession, Maurizio Bianchi, Paolo Indolfi, Paolo D'Angelo, Franca Fossati‐Bellani, Paolo Verderio, Fabio Macciardi, Paolo Radice, on behalf of the Associazione Italiana Ematologia Oncologia Pediatrica Wilms Tumor Working Group Genes Chromosomes and Cancer, 2012
Long-term results of combined preradiation chemotherapy and age-tailored radiotherapy doses for childhood medulloblastoma Maura Massimino, Graziella Cefalo, Daria Riva, Veronica Biassoni, Filippo Spreafico, Emilia Pecori, Geraldina Poggi, Paola Collini, Bianca Pollo, Laura Valentini, Paolo Potepan, Ettore Seregni, Michela Casanova, Andrea Ferrari, Roberto Luksch, Daniela Polastri, Monica Terenziani, Federica Pallotti, Carlo Alfredo Clerici, Elisabetta Schiavello, Fabio Simonetti, Cristina Meazza, Serena Catania, Marta Podda, Lorenza Gandola Journal of Neuro Oncology, 2012
The youth project at the Istituto Nazionale Tumori in Milan Andrea Ferrari, Carlo Alfredo Clerici, Michela Casanova, Roberto Luksch, Monica Terenziani, Filippo Spreafico, Daniela Polastri, Cristina Meazza, Laura Veneroni, Serena Catania, Elisabetta Schiavello, Veronica Biassoni, Marta Podda, Maura Massimino Tumori, 2012
Clinical and molecular description of a Wilms tumor in a patient with tuberous sclerosis complex Filippo Spreafico, Lucia Dora Notarangelo, Richard Fabian Schumacher, Gianfranco Savoldi, Beatrice Gamba, Monica Terenziani, Paola Collini, Silvia Fasoli, Lucio Giordano, Bercich Luisa, Fulvio Porta, Maura Massimino, Paolo Radice, Daniela Perotti American Journal of Medical Genetics Part A, 2011
Marriage and parenthood among childhood cancer survivors: A report from the italian AIEOP Off-Therapy Registry E. Pivetta, M. M. Maule, P. Pisani, D. Zugna, R. Haupt, M. Jankovic, M. Arico, F. Casale, A. Clerico, L. Cordero di Montezemolo, V. Kiren, F. Locatelli, G. Palumbo, A. Pession, M. Pillon, N. Santoro, M. Terenziani, M. G. Valsecchi, E. Dama, C. Magnani, F. Merletti, G. Pastore, for the Italian Association of Pediatric Hematology, Oncology (AIEOP) Group Haematologica, 2011
Brain Magnetic Resonance Imaging After High-Dose Chemotherapy and Radiotherapy for Childhood Brain Tumors Filippo Spreafico, Lorenza Gandola, Alfonso Marchianò, Fabio Simonetti, Geraldina Poggi, Anna Adduci, Carlo Alfredo Clerici, Roberto Luksch, Veronica Biassoni, Cristina Meazza, Serena Catania, Monica Terenziani, Renato Musumeci, Franca Fossati-Bellani, Maura Massimino International Journal of Radiation Oncology Biology Physics, 2008
Endodermal sinus tumor of the vagina Monica Terenziani, Filippo Spreafico, Paola Collini, Cristina Meazza, Maura Massimino, Luigi Piva Pediatric Blood and Cancer, 2007
Germline mutations of TP53 and BRCA2 genes in breast cancer/sarcoma families Siranoush Manoukian, Bernard Peissel, Valeria Pensotti, Monica Barile, Laura Cortesi, Silvia Stacchiotti, Monica Terenziani, Floriana Barbera, Graziella Pasquini, Simona Frigerio, Marco A. Pierotti, Paolo Radice, Gabriella Della-Torre European Journal of Cancer, 2007
Radiation effects on development of HER2-positive breast carcinomas Fabio Castiglioni, Monica Terenziani, Maria Luisa Carcangiu, Raffaella Miliano, Piera Aiello, Lorenzo Bertola, Tiziana Triulzi, Patrizia Gasparini, Tiziana Camerini, Gabriella Sozzi, Franca Fossati-Bellani, Sylvie Ménard, Elda Tagliabue Clinical Cancer Research, 2007
Celiac disease and childhood cancer Stefano Cereda, Graziella Cefalo, Filippo Spreafico, Serena Catania, Cristina Meazza, Marta Podda, Monica Terenziani Journal of Pediatric Hematology Oncology, 2006
Survival of adults treated for medulloblastoma using paediatric protocols Filippo Spreafico, Maura Massimino, Lorenza Gandola, Graziella Cefalo, Elena Mazza, Giuseppe Landonio, Emanuele Pignoli, Geraldina Poggi, Monica Terenziani, Paolo Pedrazzoli, Salvatore Siena, Franca Fossati-Bellani European Journal of Cancer, 2005
Bilateral preaxial polydactyly in a WAGR syndrome patient Siranoush Manoukian, John A. Crolla, Palma M.A. Mammoliti, Maria Adele Testi, Rinaldo Zanini, Maria Luisa Carpanelli, Elena Piozzi, Gabriella Sozzi, Giovanna De Vecchi, Monica Terenziani, Filippo Spreafico, Paola Collini, Paolo Radice, Daniela Perotti American Journal of Medical Genetics, 2005
Adult Wilms' tumor: A monoinstitutional experience and a review of the literature Monica Terenziani, Filippo Spreafico, Paola Collini, Luigi Piva, Daniela Perotti, Marta Podda, Lorenza Gandola, Maura Massimino, Stefano Cereda, Graziella Cefalo, Roberto Luksch, Michela Casanova, Andrea Ferrari, Daniela Polastri, Pinuccia Valagussa, Franca Fossati‐Bellani Cancer, 2004
Gallium scan in adolescents and children with Hodgkin's disease (HD): Treatment response assessment and prognostic value Quarterly Journal of Nuclear Medicine, 2003
Renal cell carcinoma in children: A clinicopathologic study Paolo Indolfi, Monica Terenziani, Fiorina Casale, Modesto Carli, Gianni Bisogno, Amalia Schiavetti, Antonia Mancini, Roberto Rondelli, Andrea Pession, Alessandro Jenkner, Paolo Pierani, Paolo Tamaro, Bruno De Bernardi, Andrea Ferrari, Nicola Santoro, Maria Giuliano, Giovanni Cecchetto, Luigi Piva, Gianmarco Surico, M. Teresa Di Tullio Journal of Clinical Oncology, 2003
High response rate to cisplatin/etoposide regimen in childhood low-grade glioma Maura Massimino, Filippo Spreafico, Graziella Cefalo, Riccardo Riccardi, John David Tesoro-Tess, Lorenza Gandola, Daria Riva, Antonio Ruggiero, Laura Valentini, Elena Mazza, Lorenzo Genitori, Concezio Di Rocco, Piera Navarria, Michela Casanova, Andrea Ferrari, Roberto Luksch, Monica Terenziani, Maria Rosa Balestrini, Cesare Colosimo, Franca Fossati-Bellani Journal of Clinical Oncology, 2002
Psychological aspects in patients with surgical amputations in pediatric age for malignant tumor Italian Journal of Pediatrics, 2001
Synovial sarcoma in children. Experience of the Istituto Nazionale Tumori, Milano Italian Journal of Pediatrics, 2001
Effects of recombinant human granulocyte-macrophage colony-stimulating factor in an intensive treatment program for children with Ewing's sarcoma Haematologica, 2001
Pilot study of primary chemotherapy with doxorubicin plus paclitaxel in women with locally advanced or operable breast cancer Seminars in Oncology, 1997